Dana-Farber Cancer Institute

Dana-Farber Cancer Institute Dana-Farber Cancer Institute is committed to providing expert, compassionate care.
(3752)

Dana-Farber Cancer Institute is committed to providing expert, compassionate care to children and adults with cancer, while advancing the understanding, treatment, cure, and prevention of cancer and related diseases.

05/26/2026

Join Dana-Farber Cancer Institute’s Young and Strong program for a virtual Sexual Health Workshop led by Sharon Bober, PhD, director of Dana-Farber's Sexual Health Program.

🗓 Wednesday, June 10 | 7:00–8:30 p.m. ET

This workshop will explore how treatment can affect s*x and intimacy, and offer practical strategies for communication, connection, and navigating these changes with your partner.

Open to couples of all backgrounds, identities, and s*xual orientations who have faced a young adult breast cancer diagnosis.

If you have any questions, please email [email protected].

To register, please visit: https://redcapdfci.dfci.harvard.edu/redcap/surveys/?s=7EPX8LH4ERA89M4A

Thanks to new clinical trial results and novel targeted agents, patients with chronic lymphocytic leukemia (CLL) now hav...
05/25/2026

Thanks to new clinical trial results and novel targeted agents, patients with chronic lymphocytic leukemia (CLL) now have several options for first-line therapy.

“The research that we have done over the last 10-15 years has transformed CLL therapy and continues to transform CLL therapy, giving patients highly effective and well tolerated treatment options that are only continuing to improve with our new research,” says Jennifer Brown, MD, PhD, director of the CLL Center.

Explore the leading treatment approaches: https://bit.ly/49iPSvZ

In his third year of annual bloodwork, Jerome “Jerry“ Krasnow showed signs of anemia and was referred to a hematologist....
05/24/2026

In his third year of annual bloodwork, Jerome “Jerry“ Krasnow showed signs of anemia and was referred to a hematologist. That doctor diagnosed Jerry with multiple myeloma – a form of blood cancer.

“Most people with multiple myeloma find out about their diagnosis because they are in pain or breaking bones,“ says Jerry, who was diagnosed at age 70 and is now 78. “I haven‘t experienced any of those symptoms because they caught it so early.“

For the past seven years, Jerry has been treated for multiple myeloma, where he is currently participating in a clinical trial. His journey involved a second opinion, a trip to Hawaii, victories against side effects, and substantial life changes to facilitate his participation in the trial.

Throughout, Jerry and his partner of 45 years, Barbara Zubrow, have remained devoted to the good life. They kayak, bicycle, golf, and enjoy time with their grandchildren. When they are in Boston for treatments, they visit museums and restaurants – including one in Chinatown that Jerry has been dining in since 1967 when he was a student at Boston University.

“I‘m doing fabulously,“ says Jerry.

When Jerry was first diagnosed with cancer by the hematologist near his home in Hartford, Connecticut, Barbara insisted on a second opinion. After researching multiple options, she suggested Dana-Farber.

“At the time, Dana-Farber was doing research and developing new protocols for multiple myeloma,“ she says.

Within a month, Paul Richardson, MD, director of clinical research at the Jerome Lipper Multiple Myeloma Center, began treating Jerry with a standard combination therapy known as “RVD“ (lenalidomide, bortezomib, and dexamethasone) that Richardson and his team had played a leadership role in developing. Richardson‘s team also coordinated with Jerry‘s local oncologist so he could receive his treatment in Hartford.

After some adjustments to the medication, Jerry and Barbara wanted to take a vacation, but treatment had them tethered to Hartford. With a little administrative help, his medical teams arranged for him to temporarily receive treatments in Honolulu, Hawaii – something that isn‘t easy to operationalize.

“We were able to stay in Hawaii for six weeks and see all the islands,“ recalls Jerry. “What a great experience!“

Jerry is now on his third line of treatment, which is being administered as part of a clinical trial run by Richardson, and is doing well. When Jerry began treatment for multiple myeloma, there were only a few options available. But with scientific and clinical research – including research led here – there are now over 20 approved medicines and treatment approaches for the disease.

“It‘s exciting news to a person going through this, who might be wondering, ‘What is next if my current treatment doesn‘t work?‘“ says Barbara. Not only are new options available, but more are continually emerging.

“We are making continuous advances in the treatment of multiple myeloma, and not least because our patients like Jerry participate in clinical trials,“ says Dr. Richardson. “Their partnership is invaluable and it‘s a true privilege to both care for them, and in so doing, hopefully provide the best treatment.“

The trial gave Jerry the possibility of an innovative regimen or standard therapy. It also gave him access to a supportive care team of experts who referred him to specialists for various medical needs, and an outstanding research nursing team plus research coordinators.

For example, when Jerry experienced shortness of breath, his care team referred him to a cardiologist who immediately identified a medication that resolved the issue. He also worked with an expert in geriatrics, Tammy Hshieh, MD, MPH, to manage a reaction to a steroid, as well as other general medical issues relevant to his care.

The trial medicines can only be administered at Dana-Farber under U.S. Food and Drug Administration regulations, so Jerry and Barbara also opted for a significant lifestyle change to participate while staying near their family. After decades in the same house, they sold their home in Connecticut and moved to Rhode Island, near a commuter train to Boston. Now, they make an event of their train trips.

“Once we‘re off the train, we walk everywhere we go,“ says Jerry.

They also frequent Jerry‘s old haunt, New Golden Gate Seafood restaurant, in Boston‘s Chinatown. Jerry – who believes he has been eating there “for more years than anyone“ – recommends the sizzling seafood.

Last week at The Boston Globe Health Equity Summit, Narjust Florez M.D. FASCO, and Kira Bona, MD, MPH, were onstage to d...
05/23/2026

Last week at The Boston Globe Health Equity Summit, Narjust Florez M.D. FASCO, and Kira Bona, MD, MPH, were onstage to discuss practical strategies to increase equity, access and inclusion in cancer care.

Their conversation explored the real-world barriers many patients face across the cancer journey — and the importance of building systems that improve access to screening, treatment, clinical trials and supportive care for every community.

The continuity of every profession relies on a new generation of practitioners who join the field. But for biomedical re...
05/22/2026

The continuity of every profession relies on a new generation of practitioners who join the field. But for biomedical research, early career investigators are particularly vital because they bring the new ideas and passion that drive innovation. And innovation is what powers the discovery of new treatments that improve patients' lives.

"Trainees and early career faculty come to biomedical research because they have a passion to make a difference," said Judy Garber, MD, MPH, the Susan F. Smith Chair and chief of Cancer Genetics and Prevention. "They push the field forward, not just because they are smart, but because they are driven and bring a kind of enthusiasm that really propels all of us."

The future of cancer treatment is being shaped by bold, curious, and deeply committed early career researchers — and we empower them to accelerate breakthroughs. Learn more:

Dana-Farber empowers early-career investigators to accelerate breakthroughs and build the next generation of innovators in cancer treatment.

We're just getting started. Deconstruction is underway, and the newly installed wrap is a powerful glimpse of what’s ahe...
05/21/2026

We're just getting started. Deconstruction is underway, and the newly installed wrap is a powerful glimpse of what’s ahead. It’s exciting to see this progress and take another step toward bringing our vision for the future of cancer care to life.

“It is always a good time to consider a clinical trial,” says Adrienne Waks, MD, associate director of Breast Oncology C...
05/20/2026

“It is always a good time to consider a clinical trial,” says Adrienne Waks, MD, associate director of Breast Oncology Clinical Research. “One important myth to debunk is that clinical trials are only for people who don’t have other options.”

There may be trial options for a variety of needs, and your doctor can help you understand whether one might be a good fit for you. Learn more about clinical trials — including important questions to ask when considering one:

Learn how cancer clinical trials work, how patients are protected, and what to ask your doctor before enrolling in a clinical trial.

Yesterday, Dana-Farber and Mayor Michelle Wu  吳弭 announced new funding to help preserve access to comprehensive early ca...
05/20/2026

Yesterday, Dana-Farber and Mayor Michelle Wu 吳弭 announced new funding to help preserve access to comprehensive early cancer detection services for Boston firefighters. Through a $150,000 contribution, we’ll support specialized screening protocols designed to identify cancer earlier for 500 firefighters across the city.

“Cancer has a profound impact on firefighters, who face higher risks simply because of the sacrifices they make to keep our communities safe,” said Benjamin L. Ebert, MD, PhD, president and CEO. “Dana-Farber’s mission is to ensure that every cancer patient—regardless of zip code, background, or occupation—has access to high-quality, evidence-based cancer prevention and care. We are pleased to support Mayor Wu’s firefighter cancer screening program, allowing us to bring vital screening resources directly to Boston’s firehouses, and to connect firefighters with the educational resources, care navigation, and oncology expertise available through Dana-Farber.”

Learn more: https://bit.ly/4uuK4bi

Maren was diagnosed with leukemia the day after her 8th birthday.  “Maren floors us with her positive attitude, courage,...
05/20/2026

Maren was diagnosed with leukemia the day after her 8th birthday.

“Maren floors us with her positive attitude, courage, and resilience. We are a year into treatment and even though there are sad and scary moments, she has not complained a single time. We are so grateful for the team at Dana-Farber. This journey would be nearly impossible without them. Every smile, every open door, every hello—they all make a difference,” says Maren’s mom, Vanessa.

Maren is currently responding well to treatment and her family is hoping for easier days ahead. When she grows up, she wants to become a nurse. You’ve got this, Maren!

In celebration of our annual Dana-Farber Cancer Institute Giving Day today, your donation will be TRIPLED to stretch 3x as far for patients like Maren, because cancer research and care can’t wait. Donate today: https://dana-farber.gives/GivingDay

The Leonard P. Zakim Center for Integrative Therapies and Healthy Living recently held its Integrative Therapies Fair wh...
05/19/2026

The Leonard P. Zakim Center for Integrative Therapies and Healthy Living recently held its Integrative Therapies Fair where patients, families, and staff had the opportunity to explore a variety of healing practices and wellness experiences.

Attendees enjoyed mini massages, ear acupuncture, guided meditation, and sound bath meditation, and had the chance to experience mindful eating, creative arts, qigong, tai chi, and postural restoration. Staff also shared information on integrative medicine, health coaching, and research.

Learn more about the Zakim Center's offerings and how integrative therapies support patients: https://bit.ly/4uGlGTr

As AI becomes more common in healthcare, it can be difficult to know which information to trust.Researchers are studying...
05/18/2026

As AI becomes more common in healthcare, it can be difficult to know which information to trust.

Researchers are studying how specialized AI tools may safely support cancer care, while experts urge caution with medical advice from chatbots. Learn more: https://bit.ly/3PbsQQK

Address

Boston, MA

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Alerts

Be the first to know and let us send you an email when Dana-Farber Cancer Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share